The Healthcare Technology Report named Henry O’Connell ’75 as one of its Top 50 Healthcare Technology CEOs of 2022.
This year’s list comprises a wide array of some of the most accomplished executives in the healthcare technology industry, according to a news release. They have led their firms in advancing and revolutionizing healthcare solutions, spearheading innovations in patient experience and software platforms, medical devices, therapeutics, and other areas.
This year’s awardees have also impacted the broader global community through their efforts beyond their organizations.
O’Connell is the CEO of Canary Speech, a Provo, Utah-based company that has developed technology to detect diseases and other conditions through human speech. The company’s product uses machine learning to diagnose and track conditions such as Alzheimer’s disease, Parkinson’s, PTSD, and depression.
O’Connell has over 20 years of executive and C-level experience.
Prior to Canary Speech, he was the President and CEO of MOXTEK, a leading supplier of advanced nano-optical and x-ray components used in display electronics, imaging, and analytical instrumentation. Before that, he was the President of both Dynex Technology and IDEX Corporation.
Following graduate school, he began his career at the National Institutes of Health in a neurological disease group and continued on to a successful business career specializing in turnaround situations in the tech industry. He specifically enjoys transition management with rapid change and demanding challenges.
O’Connell received a Bachelor of Arts in Biology and Psychology from Wabash College and a Master of Science in Biochemistry from the University of Connecticut School of Medicine. While at Wabash, he was an independent and a member of the track and cross country teams and the Speakers Bureau.